jump to content jump to footer

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing treatment response in melanoma and NSCLC patients receiving immune checkpoint inhibitors.

The results indicate that iRECIST is better suited for capturing atypical treatment responses to immunotherapies, especially in patients experiencing pseudoprogression. iRECIST could thus contribute to a more accurate evaluation of treatment response and improved immunotherapy outcomes.

Read more about the study here.

Research with mint mintLesion Clinical Research Standardized Reading Procedures iRECIST RECIST

Related Resources

Image of doctor looking at a prostate in mint Lesion.
Prof. Dr. Thorsten Persigehl from University Hospital Cologne discusses the use of structured reporting and AI in prostate diagnostics with mint Lesion.
Structured Reporting and AI in Radiology: Efficiency and Quality in Prostate Diagnostics
How are structured reporting and artificial intelligence transforming radiology practice? Prof. Dr. Thorsten Persigehl from University Hospital…
Dr. Madelaine Hettler from University Medical Center Mannheim discusses the RACOON-SAGA project and how it improves sarcoma diagnostics.
The interdisciplinary research project RACOON-SAGA combines functional MRI data and clinical information to enhance the pre-therapeutic characterization of soft tissue sarcomas.
Rare Tumors, Big Goals: How RACOON-SAGA Aims to Improve Therapy Decisions
Rare tumors, major challenges: The RACOON-SAGA project explores how imaging and clinical data can improve the pre-therapeutic characterization of soft…
The Template Designer in Use: Interview with Dr. Madelaine Hettler
Structured, well-organized data are the foundation of meaningful research. But how can they be captured effectively in practice? Dr. Madelaine…